The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer

Thomas, J. S.; Hanby, A. M.; Russell, N.; van Tienhoven, G.; Riddle, K.; Anderson, N.; Cameron, D. A.; Bartlett, J. M. S.; Piper, T.; Cunningham, C.; Canney, P.; Kunkler, I. H.

期刊名称Breast Cancer Research and Treatment
作者Thomas, J. S.; Hanby, A. M.; Russell, N.; van Tienhoven, G.; Riddle, K.; Anderson, N.; Cameron, D. A.; Bartlett, J. M. S.; Piper, T.; Cunningham, C.; Canney, P.; Kunkler, I. H.
卷第163卷
期第1期
印刷ISSN0167-6806
电子ISSN1573-7217
文件大小599.03KB
发表时间2017-5
DOI10.1007/s10549-017-4145-4
页码63-69

发现好书期刊，享受阅读乐趣

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer